Grail Inc
NASDAQ:GRAL

  • LAST PRICE
    13.9700
  • TODAY'S CHANGE (%)
    -0.8300 (-5.6081%)
  • Bid / Lots
    13.9500/ 10
  • Ask / Lots
    13.9600/ 6
  • Open / Previous Close
    15.0000 / 14.8000
  • Day Range
    13.5800
    15.0900
  • 52 Week Range
    12.3300
    23.3600
  • Volume
    1,045,916

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
GRAL
Grail Inc
497.3M
0.0x
---
RGNX
Regenxbio Inc
477.1M
-2.0x
---
YMAB
Y-mAbs Therapeutics Inc
496.5M
-19.9x
---
CDXC
Chromadex Corp
520.9M
383.0x
---
URGN
Urogen Pharma Ltd
472.2M
-3.5x
---
ALEC
Alector Inc
398.1M
-2.2x
---
As of 2024-11-18

Company Information

GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.

Contact Information

Headquarters
1525 O'brien DriveMENLO PARK, CA, United States 94025
Phone
650-771-9796
Fax
302-655-5049

Executives

Chairman of the Board
Charles Dadswell
President
Joshua Ofman
Chief Executive Officer
Robert Ragusa
Chief Financial Officer
Aaron Freidin
Chief People Officer
Julie Currie

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$497.3M
Revenue (TTM)
---
Shares Outstanding
33.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
$137.33
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.